公开(公告)号：US20150285805A1

公开(公告)日：2015-10-08

申请号：US14440782

申请日：2013-11-05

Applicant: OSPEDALE SAN RAFFAELE S.R.L. ,  FONDAZIONE CENTRO SAN RAFFAELE S.R.L.

Inventor： Simone Cenci ,  Francesca Fontana ,  Josè Manuel Garcia Manteiga

IPC: G01N33/574

CPC classification number: G01N33/57426 ,  G01N33/57407 ,  G01N2333/46 ,  G01N2333/47 ,  G01N2800/22 ,  G01N2800/52

Abstract: The present invention relates to a method for the prognosis of Symptomatic Multiple Myeloma (MM) and/or to monitor the response and/or the efficacy of a MM therapy comprising detecting and/or quantifying at least one marker, to relative kit and uses thereof and to relative microarray and use thereof. Markers include C3f peptide or a fragment thereof and/or other metabolites.

Abstract translation: 本发明涉及一种用于预后症状性多发性骨髓瘤（MM）和/或监测MM治疗的应答​​和/或功效的方法，包括检测和/或定量至少一种标记物，以及相关试剂盒及其用途 和相对微阵列及其用途。 标记物包括C3f肽或其片段和/或其它代谢物。